Siirry suoraan sisältöön
Cardio-Oncology
Tallenna

Cardio-Oncology

In recent years, new immunotherapies have been studied and approved in a growing number of tumors including melanoma, non-small cell lung cancer (NSCLC), and renal cell cancer (RCC). This volume provides a complete and updated state-of-art review regarding the management of cardiovascular toxicities from new immunotherapies.
Alaotsikko
Management of Toxicities in the Era of Immunotherapy
Painos
2022 ed.
ISBN
9783030977467
Kieli
englanti
Paino
310 grammaa
Julkaisupäivä
10.8.2023
Sivumäärä
122